Alterity Therapeutics Ltd Share Series Monday Management Update Transcript
Good morning, everyone, and welcome back to the SHARE Series Monday management update. My name is Remy Bernarda, and I'm a partner with Investor Relations Advisory Solutions. I'm excited to introduce you to Alterity Therapeutics, a company that we believe has a compelling investment story as they are looking to make a meaningful difference in the lives of patients with a rare disease.
(Conference Instructions)
With that, let's get started. I would now like to introduce Dr. David Stamler, who is the CEO of Alterity Therapeutics. David, can you please provide a brief overview of Alterity as well as a short background on yourself and your team and your history at the company.
Thank, Remy. Sure. Alterity is a global company with our US offices based in San Francisco and our international office based in Melbourne. We have a long history of developing drugs for neurodegenerative diseases. And I joined the company in 2017, originally as the Chief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
